Publication Name	World Journal of Gastroenterology
Manuscript ID	5496
Country	China

Received	2013-09-11 09:12
Peer-Review Started	2013-09-13 15:28
To Make the First Decision	2013-10-14 21:20
Return for Revision	2013-10-15 19:55
Revised	2013-10-17 12:27
Second Decision	2013-11-01 17:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-11-03 11:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-10 13:18
Typeset the Manuscript	2013-11-24 12:28
Publish the Manuscript Online	2013-12-11 16:13

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Autobiography
Article Title	"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
Manuscript Source	Invited Manuscript
All Author List	Jian-Yong Lei, Wen-Tao Wang and Lu-Nan Yan
Funding Agency and Grant Number
Corresponding Author	Wen-Tao Wang, MD, PhD, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China. zzphuaxiyiyuanno1@163.com
Key Words	Metroticket; Model; Survival; Hepatocellular carcinoma; Liver transplantation
Core Tip	The aim of our study was to validate the "Metroticket" predictor using a large cohort of liver transplantation (LT) patients with hepatocellular carcinoma (HCC). The predicted survival rates for all 230 cases, as calculated by the Metroticket model, were 64.7% and 56.2% at 3 and 5 years, respectively, and the observed survival rates for these patients were 71.3% and 62.2%, respectively. For the 23 cases with macrovascular invasion, the predicted 5-year survival rate was 43.5%, whereas the observed 5-year survival rate was only 8.7%. The Metroticket model can be used to accurately predict survival in HCC-related LT cases with an absence of macrovascular invasion.
Publish Date	2013-12-11 16:13
Citation	Lei JY, Wang WT, Yan LN. “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China. World J Gastroenterol 2013; 19(44): 8093-8098
URL	http://www.wjgnet.com/1007-9327/full/v19/i44/8093.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i44.8093

Full Article (PDF)	WJG-19-8093.pdf
Manuscript File	5496-Review.doc
Answering Reviewers	5496-Answering reviewers.pdf
Copyright License Agreement	5496-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5496-Language certificate.pdf
Peer-review Report	5496-Peer reviews.pdf
Scientific Editor Work List	5496-Scientific editor work list.doc